NovaBay Pharmaceuticals, Inc. (NBY)

NYSEAMERICAN: NBY · Real-Time Price · USD

0.5501

-0.0139 (-2.46%)

At close: May 12, 2025, 4:00 PM

0.5501

0.00 (0.00%)

After-hours: May 12, 2025, 8:00 PM EDT

NovaBay Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Operating Revenue	9.75	10.46	14.37	10.18	9.92	Upgrade
Other Revenue	0.03	-	0.03	0.02	0.02	Upgrade
Revenue	9.78	10.46	14.4	10.2	9.93	Upgrade
Revenue Growth (YoY)	-6.45%	-27.42%	41.16%	2.72%	50.54%	Upgrade
Cost of Revenue	3.3	4.37	6.62	3.69	3.97	Upgrade
Gross Profit	6.48	6.08	7.78	6.52	5.96	Upgrade
Selling, General & Admin	11.41	10.15	15.29	15.33	12.11	Upgrade
Research & Development	0.04	0.03	0.17	0.04	0.29	Upgrade
Operating Expenses	11.46	10.19	15.46	15.38	12.39	Upgrade
Operating Income	-4.97	-4.1	-7.68	-8.86	-6.43	Upgrade
Interest Expense	-0.9	-1.69	-	-	-	Upgrade
Other Non Operating Income (Expenses)	-0.44	-0.39	3.25	3.04	-5.51	Upgrade
EBT Excluding Unusual Items	-6.31	-6.19	-4.43	-5.82	-11.93	Upgrade
Impairment of Goodwill	-	-	-4.18	-	-	Upgrade
Gain (Loss) on Sale of Assets	-0.87	-	-	-	-	Upgrade
Asset Writedown	-	-	-2.56	-	-	Upgrade
Other Unusual Items	-0.03	0.04	0.56	-	0.9	Upgrade
Pretax Income	-7.21	-6.15	-10.61	-5.82	-11.03	Upgrade
Income Tax Expense	-	-	-	-	0.01	Upgrade
Earnings From Continuing Operations	-7.21	-6.15	-10.61	-5.82	-11.04	Upgrade
Earnings From Discontinued Operations	-0.01	-3.5	-	-	-	Upgrade
Net Income	-7.22	-9.64	-10.61	-5.82	-11.04	Upgrade
Preferred Dividends & Other Adjustments	1.39	7.06	5.66	0.74	-	Upgrade
Net Income to Common	-8.61	-16.7	-16.27	-6.56	-11.04	Upgrade
Shares Outstanding (Basic)	3	0	0	0	0	Upgrade
Shares Outstanding (Diluted)	3	0	0	0	0	Upgrade
Shares Change (YoY)	2730.00%	160.87%	29.11%	24.43%	62.08%	Upgrade
EPS (Basic)	-2.53	-139.14	-353.59	-184.09	-385.53	Upgrade
EPS (Diluted)	-2.53	-139.14	-353.59	-184.09	-385.53	Upgrade
Free Cash Flow	-5.4	-4.65	-6.77	-9.24	-4.75	Upgrade
Free Cash Flow Per Share	-1.59	-38.77	-147.09	-259.45	-165.79	Upgrade
Gross Margin	66.26%	58.19%	54.02%	63.85%	60.04%	Upgrade
Operating Margin	-50.85%	-39.23%	-53.32%	-86.85%	-64.69%	Upgrade
Profit Margin	-88.01%	-159.70%	-112.92%	-64.28%	-111.12%	Upgrade
Free Cash Flow Margin	-55.16%	-44.51%	-46.97%	-90.59%	-47.78%	Upgrade
EBITDA	-4.93	-4.05	-7.2	-8.74	-6.38	Upgrade
EBITDA Margin	-50.44%	-38.75%	-49.96%	-85.68%	-64.17%	Upgrade
D&A For EBITDA	0.04	0.05	0.48	0.12	0.05	Upgrade
EBIT	-4.97	-4.1	-7.68	-8.86	-6.43	Upgrade
EBIT Margin	-50.85%	-39.23%	-53.32%	-86.85%	-64.69%	Upgrade
Revenue as Reported	9.78	10.46	14.4	10.2	9.93	Upgrade
Advertising Expenses	0.7	1.1	2	3.2	1.7	Upgrade

Updated Nov 7, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q